About this Event
Inspired by research from across the Cancer Grand Challenges portfolio, this conference will bring together experts across disciplines to examine the interplay of mutagenesis and promotion, moving towards an integrated mechanistic framework of cancer development. It will explore how genetic alterations interact with tissue context, environmental exposures, and clonal selection to drive cancer risk and progression. The meeting aims to catalyse new collaborations and identify opportunities for cancer prevention, early intervention, and therapeutic innovation.
SCIENTIFIC STEERING COMMITTEE
This conference is being organised by a dedicated steering committee, chaired by Allan Balmain (University of California, San Francisco). The committee members are: Paul Brennan (International Agency for Research on Cancer), Nura Lopez Bigas (Institute for Research in Biomedicine), James DeGregori (University of Colorado Cancer Center)
CONTACT
Registration and abstract submission will open in autumn 2026.
Email [email protected] to join the waitlist!
Event venue
The Royal Society, 6-9 Carlton House Terrace, London, United Kingdom
Concerts, fests, parties, meetups — all the happenings, one place.